Causes and Mechanisms of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)

Primary Infectious Causes

• Viral infections account for approximately one-third of AECOPD episodes, with common culprits including rhinovirus, coronavirus, influenza B, and parainfluenza, and bacterial infections are frequently implicated, with common pathogens including Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae 1
• Molecular typing of sputum isolates has shown that acute exacerbations are often associated with a new strain of a preexisting bacterial organism, supporting the causative role of bacteria 1
• Viral respiratory infections can predispose airways to bacterial superinfection by interfering with mucociliary clearance, impairing bacterial killing by pulmonary macrophages, and increasing the risk of aspirating secretions containing bacteria 1

Comorbidity-Related Causes

• Cardiovascular conditions, such as systemic arterial hypertension, acute heart decompensation/heart failure, atrial fibrillation, and pulmonary embolism, can trigger or mimic AECOPD, according to the European Respiratory Society and American Thoracic Society 2, 3
• Other conditions that may trigger or complicate AECOPD include pneumonia, pneumothorax, and lung cancer 4

Pathophysiological Mechanisms

• Exacerbations are characterized by greater production of mucus, increased cough and wheeze, and increased sputum purulence and volume, which are associated with a worsening of symptoms 4, 5

Diagnostic Approach

• Chest radiography is essential to exclude pneumonia, pneumothorax, pulmonary edema, and lung cancer, and differential diagnoses that must be excluded include acute coronary syndrome, worsening congestive heart failure, and pulmonary embolism, as recommended by clinical guidelines 4
• Sputum culture and sensitivity are recommended when purulent sputum is present, previous antibiotic treatment was ineffective, or in severe exacerbations requiring hospitalization, according to clinical guidelines 4

Cardiovascular Comorbidities and Thrombocytopenia in COPD Exacerbations

Mechanistic Links

• Cardiovascular complications—including acute cardiac decompensation, atrial fibrillation, and pulmonary embolism—can precipitate thrombocytopenia in patients experiencing an acute COPD exacerbation. 6

Clinical Pitfalls

• Clinicians should not assume that every episode of acute respiratory worsening in COPD patients is a simple exacerbation; underlying cardiovascular comorbidities such as heart failure, pulmonary embolism, or acute coronary syndrome may simultaneously drive respiratory decline and thrombocytopenia. 6

Evidence‑Based Distinction and Management of COPD Exacerbation vs. Acute Radiation‑Induced Lung Injury

Clinical History

• Patients with chronic obstructive pulmonary disease frequently have a prior history of similar exacerbations, indicating a recurrent pattern of acute worsening episodes. 7

Diagnostic Imaging

• In the setting of a COPD exacerbation, chest radiography may demonstrate hyperinflation or appear normal; the study is essential to rule out alternative diagnoses such as pneumonia, pneumothorax, pulmonary edema, or heart failure. 7

Therapeutic Approach When Both Conditions Co‑exist

• Management of patients who have both an infectious COPD exacerbation and acute radiation pneumonitis should combine bronchodilator therapy and antibiotics (targeting the COPD component) with systemic corticosteroids (addressing the radiation‑induced inflammation). 8

Differentiating Lower Respiratory Tract Infection from Acute Infective COPD Exacerbation

Diagnostic Imaging

• Chest radiography is mandatory for every COPD patient with acute respiratory worsening to rule out pneumonia, pneumothorax, pulmonary edema, and lung cancer. The British Thoracic Society (BTS) recommends this as a first‑line investigation. 9
• The presence of a new infiltrate on chest X‑ray reclassifies the episode as community‑acquired pneumonia (CAP) rather than an acute exacerbation of COPD (AECOPD). This definition is stipulated by the European Respiratory Society (ERS) guidelines. 10

Clinical Criteria for AECOPD (Anthonisen)

• AECOPD is defined by the British Thoracic Society as a worsening of baseline dyspnea, cough, and/or sputum beyond day‑to‑day variability that requires a change in management. 9
• Increased sputum purulence is the most specific symptom for bacterial involvement, and together with increased sputum volume or dyspnea forms the “cardinal symptoms.” 9
• Antibiotics are indicated when at least two cardinal symptoms are present, one of which must be sputum purulence (Anthonisen criteria). This guides antibiotic use in the absence of radiographic pneumonia. 9
• When the above criteria are met, a 5–7‑day course of antibiotics (e.g., amoxicillin‑clavulanate, doxycycline, or a macrolide) is recommended. BTS guidance. 9

Indicators Suggestive of Pneumonia (LRTI)

• New focal chest signs (e.g., crackles or bronchial breathing), fever persisting >4 days, or severe dyspnea/tachypnea disproportionate to the patient’s baseline COPD should raise suspicion for pneumonia. ERS recommendation. 10
• High fever (>38.5 °C) or rigors, pleuritic chest pain, and new focal crackles are red‑flag features uncommon in uncomplicated AECOPD. ERS recommendation. 10

Management Strategies

AECOPD without Radiographic Infiltrate

• Increase short‑acting bronchodilators (β‑agonists ± anticholinergics). BTS protocol. 9
• Prescribe oral corticosteroids (prednisone 30–40 mg daily for 5 days). BTS protocol. 9
• Add antibiotics only if the Anthonisen criteria are satisfied (≥2 cardinal symptoms with purulence), using a 5–7‑day regimen. BTS protocol. 9

Pneumonia (LRTI) in a COPD Patient

• Treat as community‑acquired pneumonia with broader‑spectrum antibiotics covering typical and atypical pathogens for 7–10 days. ERS guideline. 10
• Continue baseline COPD maintenance therapy and provide short‑acting bronchodilators as needed. ERS guideline. 10
• Consider systemic corticosteroids (same regimen as for AECOPD) and monitor closely for respiratory failure, with hospitalization if indicated. ERS guideline. 10

Exclusion of Alternative Diagnoses

• When evaluating acute respiratory worsening, clinicians must also exclude pneumothorax, left‑ventricular failure/pulmonary edema, pulmonary embolism, acute coronary syndrome, lung cancer, and upper‑airway obstruction. BTS recommendations. 9

All statements are derived from cited guideline sources; strength of evidence was not explicitly graded in the referenced documents.